Ciprofloxacin - aurikulär
Generic name
Ciprofloxacin - aurikulär
Brand name
ATC Code
S02AA15
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIINFECTIVES
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Antiinfectives | ||
|---|---|---|
| S02AA04 | ||
| ANTIINFECTIVES | ||
|---|---|---|
| S02AA04 | ||
References
- Pierre Fabre Pharma GmbH, SmPC PANOTILE® CIPRO 1 mg Ohrentropfen, Lösung (56662.00.00), 07/2023
- Novartis Pharma GmbH, SmPC Ciloxan® 3 mg/mL Ohrentropfen, Lösung (51202.00.00), 04/2018
- INFECTOPHARM Arzneimittel und Consilium GmbH, SmPC INFECTOCIPRO® 2 mg/mL Ohrentropfen Lösung im Einzeldosisbehältnis (74133.00.00), 09/2015
Changes
Therapeutic Drug Monitoring
Overdose
